Exploring the Potential Long-term Impact of SARS-CoV-2 on Protein Misfolding and Amyloid-related Conditions

被引：0
作者：
Rashid, Md Harun [1 ]
Singha, Srinjana [1 ]
Arshad, Faheem [2 ]
Sen, Priyankar [1 ]
机构：
[1] VIT Univ, Vellore Inst Technol, Ctr Bio Separat Technol CBST, Technol Tower, Vellore 632014, Tamil Nadu, India
[2] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bengaluru, Karnataka, India
来源：
PROTEIN AND PEPTIDE LETTERS | 2024年 / 31卷 / 08期
关键词：
COVID-19; amyloidosis; amyloid beta; SARS-CoV-2; spike protein; protein misfolding; AA AMYLOIDOSIS; COVID-19; VACCINATION; COMPLICATIONS; INFECTION; RECEPTOR; RISK;
D O I：
10.2174/0109298665333817240821111641
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The long-term impact of the COVID-19 pandemic concerns risk to human health, particularly its potential association with protein misfolding and amyloidosis. This review article explores the causality relationship between SARS-CoV-2 infection, and protein misfolding, leading to amyloid-related conditions. It delves into the mechanisms by which viral proteins may accelerate amyloid formation, exacerbating post-infection complications, including neurological sequelae. Drawing from interdisciplinary research and clinical observations, the potential links between COVID-19, vaccination, and amyloidosis, emphasize the importance of understanding the long-term effect of post-COVID symptoms. This review examines the potential role of COVID-19-related proteins in the formation of amyloid in other related proteins of amyloidosis.
引用
收藏
页码：602 / 610
页数：9
相关论文
共 50 条
  • [41] Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks
    Gallichotte, Emily N.
    Nehring, Mary
    Young, Michael C.
    Pugh, Sierra
    Sexton, Nicole R.
    Fitzmeyer, Emily
    Quicke, Kendra M.
    Richardson, Megan
    Pabilonia, Kristy L.
    Ehrhart, Nicole
    Fosdick, Bailey K.
    VandeWoude, Sue
    Ebel, Gregory D.
    MICROBIOLOGY SPECTRUM, 2021, 9 (01): : 1 - 11
  • [42] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Almehdi, Ahmed M.
    Khoder, Ghalia
    Alchakee, Aminah S.
    Alsayyid, Azizeh T.
    Sarg, Nadin H.
    Soliman, Sameh S. M.
    INFECTION, 2021, 49 (05) : 855 - 876
  • [43] Potential antiviral peptides targeting the SARS-CoV-2 spike protein
    Ibrahim Khater
    Aaya Nassar
    BMC Pharmacology and Toxicology, 23
  • [44] Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
    Giuseppe Deganutti
    Filippo Prischi
    Christopher A. Reynolds
    Journal of Computer-Aided Molecular Design, 2021, 35 : 195 - 207
  • [45] Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
    Iroegbu, Joy D.
    Ifenatuoha, Chibuzor W.
    Ijomone, Omamuyovwi M.
    NEUROLOGICAL SCIENCES, 2020, 41 (06) : 1329 - 1337
  • [46] Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff
    Gallichotte, Emily N.
    Nehring, Mary
    Stromberg, Sophia
    Young, Michael C.
    Snell, Ashley
    Daniels, Josh
    Pabilonia, Kristy L.
    VandeWoude, Sue
    Ehrhart, Nicole
    Ebel, Gregory D.
    MSPHERE, 2022, 7 (04)
  • [47] Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis
    Quiroga, Borja
    Jose Soler, Maria
    Ortiz, Alberto
    Gansevoort, Ron T.
    Leyva, Alba
    Rojas, Jose
    de Sequera, Patricia
    VACCINES, 2022, 10 (10)
  • [48] Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
    Ferrari, Davide
    Di Resta, Chiara
    Tomaiuolo, Rossella
    Sabetta, Eleonora
    Pontillo, Marina
    Motta, Andrea
    Locatelli, Massimo
    VACCINE, 2021, 39 (31) : 4256 - 4260
  • [49] Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities
    Kumar, Rahul
    Aktay-Cetin, Oeznur
    Craddock, Vaughn
    Morales-Cano, Daniel
    Kosanovic, Djuro
    Cogolludo, Angel
    Perez-Vizcaino, Francisco
    Avdeev, Sergey
    Kumar, Ashok
    Ram, Anil Kumar
    Agarwal, Stuti
    Chakraborty, Ananya
    Savai, Rajkumar
    Perez, Vinicio de Jesus
    Graham, Brian B.
    Butrous, Ghazwan
    Dhillon, Navneet K.
    PLOS PATHOGENS, 2023, 19 (01)
  • [50] Exploring the long-term seroprevalence of SARS-CoV-2 antibodies in infants born to women with clinical or laboratory-confirmed COVID-19
    Jiwani, Uswa
    Ali, Khushboo Qaim
    Khowaja, Saleema
    Iqbal, Junaid
    Aamir, Almas
    Ansari, Uzair
    Habib, Muhammad Atif
    Soofi, Sajid
    Ariff, Shabina
    PEDIATRICS AND NEONATOLOGY, 2024, 65 (03) : 293 - 297
12345